ENDRA Life Sciences NDRA Cash Flow Statement (2016-2026)

NASDAQ NDRA
$4.63 +0.22 (+4.81%)
As of: Oct 21, 2026 · 10:49 AM EDT
Reported Financials

ENDRA Life Sciences Quarterly Cash Flow Statement

Periods 42 quarters
Latest Jun 2026

ENDRA Life Sciences reported cash from operations of -$0.93M and free cash flow of -$0.93M for the quarter ended Jun 2026, up 16.7% year over year. This cash flow statement covers 42 quarters of results from Mar 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-2.66M19.36M-2.86M-3.59M-3.44M-3.29M2.94M-2.56M14.10M-18.66M-2.78M-2.23M-2.35M-4.15M-1.04M-1.23M-1.60M-3.17M-1.31M0.16M
Depreciation and DepletionDep. & Depletion
0.03M0.02M0.02M0.02M0.02M0.03M0.03M0.04M0.03M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
-0.03M0.61M-0.03M-0.03M-0.04M
Depreciation & Amortization (CF)Dep. & Amort.
0.03M0.02M0.02M0.02M0.02M0.03M0.03M0.04M0.03M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based CompensationStock Comp.
0.33M0.41M0.29M-0.29M0.91M0.29M0.24M0.26M0.25M0.25M0.32M0.19M-0.04M0.10M0.08M0.04M0.14M0.01M0.57M0.54M
Gains from Investment SecuritiesGains Investment
3.07M0.01M0.74M1.29M
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
0.03M0.03M0.03M0.03M0.04M0.51M-0.22M0.50M-0.14M3.98M2.31M-0.38M-0.06M0.27M-0.09M0.04M0.07M
Change in Working Capital
Change in ReceivablesChange Receivables
Change in InventoryChange Inventory
-0.17M1.61M0.65M-1.74M-0.26M2.71M0.09M0.02M0.00M0.23M-0.14M-0.33M
Change in Accured ExpensesChange Accured Exp.
-0.07M-0.04M-0.19M0.14M0.20M-0.04M0.12M0.20M0.13M-1.27M0.34M0.13M-0.54M-0.12M-0.07M0.01M0.22M-0.05M0.08M-0.05M
Change in Other Operating AssetsOther Assets Change
-0.21M1.74M-0.29M0.80M-0.08M-0.79M-0.13M0.18M0.00M-0.21M-0.04M0.18M-0.35M-0.04M-0.09M-0.07M0.21M-0.05M-0.39M-0.13M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.03M-0.03M-0.03M-0.03M-0.03M-0.03M0.45M-0.07M-0.08M-0.45M0.28M-0.09M-0.33M-0.03M0.00M-0.03M-0.03M-0.03M-0.03M-0.03M
Other Working Capital ChangesOther WC Changes
0.18M-1.77M0.25M-0.83M0.05M0.75M0.58M-0.25M-0.08M-0.24M0.32M-0.26M0.03M0.01M0.09M0.04M-0.24M0.02M0.36M0.10M
Cash from OperationsCash from Ops.
-2.75M-2.65M-3.10M-3.33M-3.25M-3.09M-2.51M-2.27M-2.60M-2.17M-2.14M-2.08M-1.66M-1.52M-1.29M-1.11M-1.16M-1.61M-1.12M-0.93M
Investing Activities
Capital ExpendituresCapex
0.09M0.06M0.01M0.04M0.03M0.01M0.03M-0.01M0.02M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00M
Change in Property, Plant and EquipmentChange in PP&E
-0.09M-0.06M-0.01M-0.04M-0.03M-0.01M-0.02M0.01M-0.02M
Change in IntangiblesChange Intangibless
-0.45M-2.24M
Cash from Investing ActivitiesCash from Investing
-0.09M-0.06M-0.01M-0.04M-0.03M0.00M-0.02M0.01M-0.02M-3.00M0.45M2.22M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
0.03M
Non-Current Debt
-0.03M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.03M
Change in Capital Stock
Common Stock IssuedStock Issued
10.79M-9.97M0.85M7.55M4.73M1.11M1.67M0.50M7.34M0.00M-1.15M0.15M0.86M0.15M0.07M0.26M0.09M
Net Shares Issued and RepurchasedNet Shares Issued
10.79M-9.97M0.85M7.55M4.73M1.11M1.67M0.50M7.34M0.00M-1.15M0.15M0.86M0.15M0.07M0.26M0.09M
Net Equity Issued and RepurchasedNet Equity Issued
10.79M-9.97M0.85M7.55M4.73M1.11M1.67M0.50M7.34M0.00M-1.15M0.15M0.86M0.15M0.07M0.26M0.09M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
Dividends Paid - Common and PrefferdDiv Paid (Total)
Cash from Financing ActivitiesCash from Financing
0.50M0.32M0.85M7.55M4.73M1.11M1.67M0.47M7.34M0.00M0.15M0.86M0.15M4.58M0.26M3.89M
Additional items
Change in Cash
-2.25M-2.33M-2.33M4.15M-3.26M-3.13M-2.53M2.46M-1.48M-0.50M-1.70M5.27M-1.66M-1.52M-1.16M-0.26M-1.01M-0.03M-0.41M5.18M
Ending Cash Balance
11.79M9.46M7.13M11.28M8.02M4.89M2.36M4.82M2.83M4.75M3.23M2.06M1.81M0.79M0.76M0.36M5.54M
Free Cash FlowFCF
-2.75M-2.65M-3.19M-3.39M-3.26M-3.13M-2.53M-2.27M-2.60M-2.18M-2.17M-2.07M-1.66M-1.52M-1.31M-1.11M-1.16M-1.61M-1.12M-0.93M
Net Cash FlowNCF
-2.25M-2.33M-2.33M4.15M-3.26M-3.13M-2.53M2.46M-1.48M-0.50M-1.70M5.27M-1.66M-1.52M-1.16M-0.26M-1.01M-0.03M-0.41M5.18M
Interest Paid
0.04M0.02M0.06M0.04M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M

ENDRA Life Sciences Cash Flow Statement API

Pull ENDRA Life Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NDRA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY